Live News EQUITY L impact Jul 22, 2026, 12:00 PM UTC

MNPR - Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease

SquawkNews Newsroom 3 updates Updated Jul 22, 2026, 12:03 PM UTC

Story updates

12:00:47 PM UTC

SquawkNews

12:02:15 PM UTC

SquawkNews

MNPR Monopar initiates rolling NDA submission for alxn1840 in Wilson disease

12:03:30 PM UTC

SquawkNews

Monopar Therapeutics...

MNPR - Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease